Categories Uncategorized

UPDATE 1-AstraZeneca’s Tagrisso gets broader US FDA nod for lung cancer

UPDATE 1-AstraZeneca’s Tagrisso gets broader US FDA nod for lung cancer By Reuters Staff 2 Min Read FILE PHOTO: A sign is seen at an AstraZeneca site in Macclesfield, central England May 19, 2014. REUTERS/Phil Noble/File Photo (Reuters) -AstraZeneca Plc said on Monday that the U.S. drug regulator had approved Tagrisso, the British drugmaker’s top […]

Read More
Categories Multiple Myeloma

Antengene Announces its US Partner, Karyopharm Therapeutics Inc., has received FDA Approval …

Antengene Announces its US Partner, Karyopharm Therapeutics Inc., has received FDA Approval … –Oral XPOVIO® Approval as Combination Therapy in Patients with Multiple Myeloma After At Least One Prior Therapy Significantly Expands the XPOVIO® Addressable Patient Population – — Oral XPOVIO® is Now the Only Approved Multiple Myeloma Drug Indicated as Part of a Once-Weekly […]

Read More